As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...
Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...
While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...
The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...